Udenolone Injection (Triamcinolone Acetonide)
Triamcinolone Acetonide 40mg
Prescription medication
International Pharmaceutical Co., Ltd.
MFDS item code 198100080 · Notified 1981.04.17 · Insurance code 643701881
Treatment of joint and rheumatic diseases, skin and allergic diseases, endocrine and collagen diseases, eye diseases, gastrointestinal diseases, and blood disorders
This medication is used for short-term treatment of various inflammatory diseases such as arthritis, bursitis, and tendinitis, by direct injection into the joints or bursae. It is also administered as a muscle injection in cases where oral intake is difficult due to conditions like adrenal insufficiency, rheumatic disorders, skin diseases, allergic diseases, ocular diseases, gastrointestinal diseases, and hematological disorders. It can also be used intradermally for treating lichen planus, early keloids, and alopecia areata. This drug improves symptoms and prevents disease progression by regulating inflammation and immune responses. It is effectively used for easing inflammation and immune regulation in various diseases.
1. Intra-articular, intrasynovial, and intratendinous sheath injection Adults: Administer 2 ~ 40 mg of triamcinolone acetonide per dose, in principle at intervals of at least 2 weeks; adjust the dose as appropriate. 2. Intramuscular injection Adults: The usual initial dose is 40 mg of this medicine, injected deep into the gluteal muscle. Adjust within the range of 20 ~ 80 mg at intervals of 1 ~ 2 weeks according to the patient's response to treatment. 3. Local intradermal injection Adults: The initial dose of this medicine varies according to the condition. However, local tissue atrophy may occur with high doses; therefore, inject 0.2 ~ 1 mg per dose, up to 10 mg, once weekly.
Children aged 12 years and older: The usual initial dose is 40 mg of this medicine, injected deep into the gluteal muscle. Adjust within the range of 20 ~ 80 mg at intervals of 1 ~ 2 weeks according to the patient's response to treatment. Children aged 6 ~ 12 years: An initial dose of 40 mg is appropriate; adjust according to age, body weight, and symptoms. Use is not recommended in children 6 years of age and younger.
This medication is in suspension form and should not be administered via intravenous injection. Injection into the epidural space or spinal canal is also prohibited, as serious side effects may occur in those areas. This drug should not be used in patients with allergies to it or its components. It can worsen the condition in patients with infections or systemic fungal infections due to its immune-suppressive effects, hence it must not be administered. Caution is also needed in patients with thrombocytopenia, purpura, herpes simplex, herpes zoster, and chickenpox. It is advisable not to administer if there are infections around the joints, bursae, or tendons, as it may exacerbate the condition. In patients with unstable joints, the symptoms may worsen. Patients with specific diseases must use this drug cautiously. Caution is warranted in patients with tuberculosis, keratitis, cataracts, glaucoma, hypertension, electrolyte imbalances, thrombosis, and history of myocardial infarction due to the risk of side effects. Patients recovering from surgery, those with peptic ulcers, mental disorders, or osteoporosis should also be treated with caution. Patients with infectious diseases, hypothyroidism, liver disease, renal failure, congestive heart failure, and diabetes also require careful monitoring due to the potential for worsening conditions. Various side effects may occur during the use of this medication; thus, the patient's condition should be monitored closely. Imbalances of bodily fluids and electrolytes, hypertension, and edema, as well as muscle pain, osteoporosis, and increased risk of fractures may arise. Gastrointestinal issues such as stomach ulcers, nausea, vomiting, and appetite changes may occur. Skin issues like delayed wound healing, rash, and hair loss can also appear. Neurological issues such as headaches, dizziness, insomnia, and seizures have been reported, and in severe cases, spinal injury may be a concern. The endocrine system and eye health can also be affected, necessitating regular examinations. Abnormalities in the blood and metabolic systems, respiratory deterioration, and shock reactions may occur; hence caution is required. This medication can interact with other drugs, so it is vital to notify any medications being taken concurrently. In particular, concomitant use with drugs that affect enzymes involved in drug metabolism in the liver may increase the risk of side effects. Dose adjustment and monitoring are necessary when used alongside non-steroidal anti-inflammatory drugs, anticoagulants, and diuretics. Pregnant women or those who may become pregnant should consult with a physician, as this medication may pose risks to the fetus. It is advisable to discontinue breastfeeding while using this drug, as it may transfer into breast milk. In children, side effects such as growth retardation may occur; therefore, the minimum dosage should be administered cautiously, and prolonged use can lead to issues like increased intracranial pressure. Elderly patients have a higher risk of side effects such as infections, diabetes, and osteoporosis; thus, they should be used under careful observation. When administering, avoid specific routes such as intravenous injection, spinal injection, or epidural injection, and during intramuscular injections, avoid injecting near nerves or blood vessels. If pain or blood reflux occurs during the injection, the injection site should be changed immediately.
Fluid retention, sodium retention, congestive heart failure, potassium loss, ECG changes due to venous irregularities or potassium deficiency, hypertension, edema, myalgia, arthralgia, muscle weakness, fatigue, steroid myopathy, loss of muscle mass, osteoporosis, spinal compression fractures, delayed healing of fractures, avascular necrosis of the femoral and humeral heads, pathological fractures of the ilium, idiopathic fractures, tendon rupture, gastric perforation, peptic ulcer, pancreatitis, diarrhea, nausea, vomiting, abdominal pain, heartburn, abdominal distension, ulcerative esophagitis, polydipsia, anorexia, hyperphagia, dyspepsia, abdominal bloating, gastrointestinal/bladder dysfunction, delayed wound healing, epidermal peeling, petechiae, facial erythema, sweating, purpura, striae, hirsutism, acneiform eruptions, lesions resembling erythematous lupus, suppressive responses in skin testing, alopecia, lipodystrophy, seizures, congestion, increased intracranial pressure with papilledema, dizziness, headache, neuritis or dysesthesia, euphoria, insomnia, uveitis, meningitis, incomplete/complete paraplegia and sensory disturbances, spinal infarction, paraplegia, quadriplegia, cortical visual loss, stroke, menstrual irregularities, postmenopausal vaginal bleeding, Cushing's syndrome, growth inhibition in children, secondary adrenal cortical and pituitary non-responsiveness, decreased glucose tolerance, onset of latent diabetes, increased insulin or oral hypoglycemic agent susceptibility, buffalo hump, suppression of adrenocorticotropic hormone secretion, increased intraocular pressure, glaucoma, posterior subcapsular cataract, secondary eye infections, retinal disorders, exophthalmos, leukocytosis, thrombosis, hyperglycemia, diabetes, negative nitrogen balance due to protein catabolism, exacerbation of bronchial asthma, shock, anaphylactoid reactions and symptoms, dyspnea, systemic flush, angioedema, urticaria, joint instability, pain, increased tenderness, worsening of swelling, localized tissue atrophy, retinal artery occlusion, blindness, visual disturbances, hepatitis due to hepatitis B virus proliferation, scleroderma renal crisis, vasculitis, thrombophlebitis, thromboembolism, exacerbation or concealment of infectious diseases, syncope
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and must be stored in a container that does not allow light to enter; it is safe to store at room temperature between 1 and 30 degrees Celsius. Therefore, it is crucial to avoid direct sunlight and not to place it in excessively hot or cold environments.
A white vial preparation containing a white suspension injection.
1 mL/each [(1 mL x 50 vials)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Triamcinolone Acetonide 40mg
Prescription medication
International Pharmaceutical Co., Ltd.
Triamcinolone Acetonide 40mg
Injections · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Triamcinolone Acetonide 1mg
Cream · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Triamcinolone Acetonide 40mg
Injections · Prescription medication
Hanol Biopharma Co., Ltd.
Triamcinolone Acetonide 1mg
OTC medication
Taegeuk Pharmaceutical Co., Ltd.
Triamcinolone Acetonide 10mg
Injections · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Triamcinolone Acetonide 40mg
Injections · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Triamcinolone Acetonide 1mg
Ointment · OTC medication
Taeguk Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.